Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inoperable Non Small Cell Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07189871
What this trial is testing

177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

Who this might be right for
Castration-Resistant Prostate Cancer (CRPC)Colorectal CancerNSCLC (Non-small Cell Lung Cancer)+7 more
Radiopharm Theranostics, Ltd 61
Not applicableLooking for participantsNCT07441941
What this trial is testing

Single-Fraction Pulmonary Ablative Radiotherapy Outcomes and Quality-of-life Workup

Who this might be right for
Oligometastatic Lung TumorNSCLC (Non-small Cell Lung Cancer)SBRT
Institut du Cancer de Montpellier - Val d'Aurelle 190
Testing effectiveness (Phase 2)Ended earlyNCT01108666
What this trial is testing

Proton Beam Radiation With Concurrent Chemotherapy and Nelfinavir for Inoperable Stage III Non Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non Small Cell Lung Cancer
Abramson Cancer Center at Penn Medicine 7
Testing effectiveness (Phase 2)Study completedNCT00960999
What this trial is testing

Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Radiation Therapy Oncology Group 94
Testing effectiveness (Phase 2)Study completedNCT00333294
What this trial is testing

Phase II Iressa + Irradiation Followed by Chemo in NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
AstraZeneca 50
Testing effectiveness (Phase 2)Study completedNCT00482014
What this trial is testing

Pemetrexed Plus Carboplatin, or Pemetrexed Plus Cisplatin With Radiation Therapy Followed by Pemetrexed in Patients With Inoperable Non-Small-Cell Lung Cancer

Who this might be right for
Non-Small-Cell Lung Cancer
Eli Lilly and Company 120
Testing effectiveness (Phase 2)Study completedNCT00173875
What this trial is testing

Iressa as a First-Line Treatment in Chemonaive Patients With Inoperable Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
National Taiwan University Hospital 108
Testing effectiveness (Phase 2)Study completedNCT00004202
What this trial is testing

Combination Chemotherapy, Radiation Therapy, and RSR13 in Treating Patients With Stage III Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Spectrum Pharmaceuticals, Inc
Testing effectiveness (Phase 2)UnknownNCT00178698
What this trial is testing

Hyperthermia/Thermal Therapy With Chemotherapy to Treat Inoperable or Metastatic Tumors

Who this might be right for
Neuroendocrine CancerSmall Cell Lung CancerNon-Small Cell Lung Cancer+1 more
The University of Texas Health Science Center, Houston 36
Early research (Phase 1)Ended earlyNCT00062335
What this trial is testing

High-Dose 3-Dimensional Conformal Radiation Therapy in Treating Patients With Inoperable Stage I, Stage II, or Stage IIIA Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
European Organisation for Research and Treatment of Cancer - EORTC 14
Early research (Phase 1)Active Not RecruitingNCT05704985
What this trial is testing

Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors

Who this might be right for
CancerSolid TumorColorectal Cancer+6 more
DEKA Biosciences 39
Not applicableUnknownNCT05027165
What this trial is testing

Prospective Evaluation of Immunological, Molecular-genetic, Image-based and Microbial Analyzes to Characterize Tumor Response and Control in Patients With Inoperable Stage III NSCLC Treated With Chemoradiotherapy Followed by Consolidation Therapy With Durvalumab

Who this might be right for
OncologyBiomarkerNSCLC, Stage III+2 more
LMU Klinikum 40
Early research (Phase 1)WithdrawnNCT05171062
What this trial is testing

Dose Escalation Trial of Bexmarilimab (FP-1305) Plus Pembrolizumab in Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
The University of Texas Health Science Center at San Antonio
Early research (Phase 1)Study completedNCT00327288
What this trial is testing

Safety Study of Imexon Plus Docetaxel in Lung, Breast or Prostate Cancer Patients

Who this might be right for
Non-small Cell Lung CancerBreast CancerProstate Cancer
AmpliMed Corporation 34
Large-scale testing (Phase 3)Study completedNCT01763645
What this trial is testing

A Safety and Efficacy Study of BCD-021 With Paclitaxel and Carboplatin Compared to Avastin With Paclitaxel and Carboplatin in Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Biocad 353
Testing effectiveness (Phase 2)Ended earlyNCT03233724
What this trial is testing

Oral Decitabine and Tetrahydrouridine as Epigenetic Priming for Pembrolizumab-Mediated Immune Checkpoint Blockade in Patients With Inoperable, or Unresectable Locally Advanced or Metastatic Non-Small Cell Lung Cancers and Esophageal Carcinomas

Who this might be right for
Carcinoma, Non-Small-Cell LungLung CancerNon-Small Cell Lung Cancer+2 more
National Cancer Institute (NCI) 9
Not applicableUnknownNCT01920789
What this trial is testing

Stereotactic Precision And Conventional Radiotherapy Evaluation

Who this might be right for
Non-small Cell Lung Cancer
Ass. Prof. Jan Nyman 102
Large-scale testing (Phase 3)Ended earlyNCT02187367
What this trial is testing

Safety & Efficacy Study of EGF Cancer Vaccine to Treat Stage IV Biomarker Positive, Wild Type EGF-R NSCLC Patients

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Bioven Europe 106
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05764928
What this trial is testing

Evaluate the Safety and Efficacy of BLEX 404 Oral Liquid Combined With Pemetrexed + Cisplatin Therapy

Who this might be right for
Nonsquamous Nonsmall Cell Neoplasm of Lung
Rgene Corporation 32
Not applicableStudy completedNCT03916367
What this trial is testing

CT-guided Radioactive I-125 Seeds Implantation for Early Stage Lung Cancer

Who this might be right for
Early Stage Non-small Cell Lung Cancer
Peking University Third Hospital 39
Next Page